VRDN
NASDAQ · Biotechnology
Viridian Therapeutics Inc
$28.49
-0.06 (-0.21%)
Performance
1D
+0.00%
1W
+12.61%
1M
+55.34%
3M
+23.55%
6M
+65.64%
1Y
+3.83%
YTD
-7.14%
Open$28.66
Previous Close$28.55
Day High$29.47
Day Low$27.86
52W High$34.29
52W Low$13.18
Volume—
Avg Volume3.26M
Market Cap2.91B
P/E Ratio—
EPS$-3.90
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$21.97
Above
SMA 200
$21.62
Above
RSI (14)
86.1
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
23 analysts
Price Target
+124.1% upside
Current
$28.49
$28.49
Target
$63.84
$63.84
$43.31
$63.84 avg
$68.31
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 85.27M | 891.8K | 430.67M |
| Net Income | -412,296,071 | -725,406,968 | -19,976,292 |
| Profit Margin | -483.6% | -84,917.7% | -4.6% |
| EBITDA | -436,728,279 | -846,793,579 | -30,128,222 |
| Free Cash Flow | — | — | -23,390,816 |
| Rev Growth | +242.1% | -53.3% | -2.2% |
| Debt/Equity | 0.12 | 0.03 | 0.27 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |